A small subset of coeliac disease (CD) patients experience persisting or recurring symptoms despite strict adherence to a gluten-free diet (GFD). When other causes of villous atrophy have been excluded, these patients are referred to as refractory celiac disease (RCD) patients. RCD can be divided in two types based on the absence (type 1) or presence (type II) of an, usually clonal, intraepithelial lymphocyte population with aberrant phenotype.
10/21/2013
Update on the Diagnosis and Management of Refractory Coeliac Disease
Recent Posts
- Advocacy Spotlight: How One Arizona Teen Helped Expand Gluten-Free Food Access Through the CD-FIRN Program
- Celiac Disease Foundation Advances Research, Policy, and Global Patient Leadership at ICDS 2026
- Teva Pharmaceuticals Announces Positive Phase 2a Results for Investigational Celiac Disease Treatment
- The Emerald Benefit: A Shining Example of Celiac Disease Advocacy
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Community Spotlight
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Impact Fund
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Recipes
- Research
- Research News
- Trending Topics
Marilyn's Message
3/18/2025
Read moreA Bold New Look for the Celiac Disease Foundation